i-SENS, Inc. 099190

KRX · South Korea · Health Technology

KRW 16,900.00-360.00 (-2.09%)

Market open· Oct 2, 2026, 3:59 AM UTC· KRW · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

i-SENS, Inc. 099190

KRX · South Korea · Health Technology

KRW 16,900.00-360.00 (-2.09%)

Market open· Oct 2, 2026, 3:59 AM UTC· KRW · Data may be delayed

Company news

Yahoo FinanceMar 23, 2026

CoaguSense Announces Agreement to Acquire DOASENSE DOAC Testing Business, Expanding Leadership in Anticoagulation Monitoring

FREMONT, Calif., March 22, 2026 (GLOBE NEWSWIRE) -- CoaguSense, Inc., a leading developer of point-of-care coagulation monitoring systems and a subsidiary of i-SENS, Inc. (KOSDAQ: 099190), today announced it has entered into a definitive asset purchase agreement to acquire the business of DOASENSE GmbH, Heidelberg, a pioneer in specialized diagnostic solutions for Direct Oral Anticoagulants (DOACs). This strategic acquisition is designed to expand CoaguSense’s portfolio beyond traditional Vitami

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.